Consistently, EPB41L4A-AS1 expression was elevated in T2DM cell models established by a persistent high level of glucose or glucosamine treatment in human primary skeletal muscle cells, human muscle source carcinoma cells, HepG2 and L02 cells. This evidence concerns the gene EPB41L4A and type 2 diabetes mellitus.